Jacobs Levy Equity Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-89,218
| Closed | -$936K | – | 1029 |
|
|
2024
Q3 | $936K | Sell |
89,218
-63,219
| -41% | -$663K | ﹤0.01% | 731 |
|
|
2024
Q2 | $1.78M | Sell |
152,437
-139,904
| -48% | -$1.64M | 0.01% | 623 |
|
|
2024
Q1 | $6.16M | Sell |
292,341
-402,843
| -58% | -$8.49M | 0.03% | 386 |
|
|
2023
Q4 | $12.5M | Buy |
695,184
+132,793
| +24% | +$2.38M | 0.06% | 276 |
|
|
2023
Q3 | $9.26M | Buy |
562,391
+1,493
| +0.3% | +$24.6K | 0.05% | 270 |
|
|
2023
Q2 | $11.2M | Sell |
560,898
-71,480
| -11% | -$1.43M | 0.06% | 262 |
|
|
2023
Q1 | $12M | Buy |
632,378
+605,255
| +2,232% | +$11.4M | 0.07% | 260 |
|
|
2022
Q4 | $615K | Buy |
27,123
+16,531
| +156% | +$375K | ﹤0.01% | 754 |
|
|
2022
Q3 | $280K | Sell |
10,592
-147,660
| -93% | -$3.9M | ﹤0.01% | 899 |
|
|
2022
Q2 | $3.91M | Sell |
158,252
-16,660
| -10% | -$412K | 0.03% | 462 |
|
|
2022
Q1 | $5.81M | Buy |
+174,912
| New | +$5.81M | 0.04% | 385 |
|
|
2021
Q3 | – | Sell |
-179,521
| Closed | -$6.97M | – | 1114 |
|
|
2021
Q2 | $6.97M | Sell |
179,521
-11,943
| -6% | -$464K | 0.05% | 372 |
|
|
2021
Q1 | $6.53M | Buy |
191,464
+164,416
| +608% | +$5.61M | 0.05% | 379 |
|
|
2020
Q4 | $1.23M | Sell |
27,048
-1,518
| -5% | -$68.9K | 0.01% | 672 |
|
|
2020
Q3 | $786K | Sell |
28,566
-5,261
| -16% | -$145K | 0.01% | 706 |
|
|
2020
Q2 | $1.25M | Buy |
+33,827
| New | +$1.25M | 0.01% | 627 |
|